bullish

PRARAM 9 HOSPITAL Plc. (PR9): 4Q25E Still In Line...

138 Views21 Jan 2026 07:21
Broker
4Q25E core profit is expected to rise YoY but edge down QoQ, in line with expectations. Valuation metrics imply up to 24% upside to Bt23.40 on ~5% long-term CAGR, in line with peers.
What is covered in the Full Insight:
  • Earnings Preview for 4Q25E
  • Valuation and Market Outlook
  • Impact of Foreign Patient Growth
  • Marketing and Cost Management
  • Looking Ahead to 1Q26E
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • PRARAM 9 HOSPITAL Plc. (PR9): 4Q25E Still In Line...
    21 Jan 2026
x